Results 111 to 120 of about 6,645 (195)

New-onset Autoimmune Diseases in Patients with Prurigo Nodularis: A Global-federated Retrospective Cohort Study. [PDF]

Acta Derm Venereol
Chang HC, Chang CC, Chu YJ, Hsu WT, Li YF, Jhang YS, Su YJ, Chen SJ, Zuberbier T, Gau SY.   +9 more
europepmc   +1 more source

Comparative safety profiles of dupilumab and nemolizumab in prurigo nodularis: an indirect META-analysis to inform clinical decision-making. [PDF]

Front Med (Lausanne)
Feng W, Wang D, Tan K, Zhang X.
europepmc   +1 more source

Quantitative Evaluation of Nemolizumab Pharmacokinetics and Efficacy in Prurigo Nodularis: A Population Pharmacokinetics and Model-Based Meta-analysis Approach. [PDF]

Dermatol Ther (Heidelb)
Takechi T, Shimizu J, Kabashima K, Ieiri I.   +3 more
europepmc   +1 more source

Recalcitrant Prurigo Nodularis Successfully Treated with Dupilumab. [PDF]

Indian Dermatol Online J
Anjaneyan G, Reddy S, Mathew L, Ponnamparambath V.   +3 more
europepmc   +1 more source

Generalized prurigo nodularis after dermatomal herpes zoster: Resolution with nemolizumab. [PDF]

JAAD Case Rep
Fason C, Tyring S.
europepmc   +1 more source

Prurigo nodularis (Hyde) [PDF]

Archiv für Dermatologie und Syphilis, 1916
openaire   +1 more source

An Atypical Manifestation: Linear Hyperkeratotic Prurigo Nodularis. [PDF]

Cureus
Likki S, Ali I, Black TA, Yang NX, McQuitty EN, Rashid RM.   +5 more
europepmc   +1 more source

Efficacy and Safety of Dupilumab in Adults with Prurigo Nodularis with or Without Atopic Comorbidities: A Subgroup Analysis from Two Randomized Phase III Clinical Trials. [PDF]

Am J Clin Dermatol
Kim BS, Gonçalo M, Ugajin T, Gao XH, Praestgaard AH, Makhija M, Zahn J, Bansal A, Wiggins S.   +8 more
europepmc   +1 more source

The Significant Role of Atopic Skin Diathesis in Prurigo Nodularis. [PDF]

Sisli Etfal Hastan Tip Bul
Erdem Y, Ntousounous OI, Ozkaya E.
europepmc   +1 more source